A 31-year-old male architect presents to the infectious disease clinic to discuss the results of recent blood work. He recently tested positive for HIV, and subsequent flow cytometry revealed a CD4 T-lymphocyte count of . The physician advises starting a daily antiretroviral regimen. The patient shakes his head and states, "I run marathons and have never felt better. I saw on a forum that these drugs destroy your liver and cause horrible fatigue. There is no way I am starting them until I actually feel ill." Which of the following is the most appropriate initial response by the physician?
- AIf you are certain about your decision, I will need to conduct a formal evaluation to confirm you have the legal competence to refuse care.
- BRegardless of your choice to take the medication, I am legally obligated to report your diagnosis to the health department.
- It is understandable to be concerned about potential adverse effects. What other information have you read regarding these treatments?Answer
- DWe can prescribe an alternative regimen; for instance, non-nucleoside reverse transcriptase inhibitors are generally free of liver toxicity risks.
- EDelaying therapy is not recommended, as your CD4 count is already below the threshold for initiating opportunistic infection prophylaxis.
Answer
The most appropriate initial response is to validate the patient's concerns and ask an open-ended question to further explore his understanding regarding the treatments.
The correct answer demonstrates patient-centered communication by validating the patient's emotions and utilizing an open-ended question. In patients expressing hesitancy or resistance based on external information, the initial step should always be to non-judgmentally explore their health beliefs. This builds a therapeutic alliance and helps the physician understand the exact nature of the misconception before attempting to provide medical facts or strong recommendations.
Step-by-Step Solution
Key Concept
Patient-centered communication and motivational interviewing principles when addressing medication hesitancy.